• Study on the Safety and Effectiveness of Etrumadenant, Quemliclustat, and Zimberelimab in Patients with Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain

  • Study on DMD06-MAB Injection for Duchenne Muscular Dystrophy in Non-Ambulant Patients

    Not recruiting

    2 1 1
    Investigated drugs:
    Italy

  • Study on the Safety of Mogamulizumab for Patients with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain

  • Study of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Italy The Netherlands Spain

  • Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Hungary Italy +3

  • Study Comparing Ribociclib and Endocrine Therapy to Chemotherapy for Patients with Intermediate-Risk HR+/HER2- Early Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Germany

  • Study of Nivolumab, Ipilimumab, Relatlimab, and Daratumumab in Patients with Recurrent and Metastatic Colon Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy

  • Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Cyprus Czechia Denmark Finland France +9

  • Study on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of SGM-101 fluorescent imaging agent to guide surgery in patients with pancreatic cancer who received prior treatment

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

powered by